The Influence of Menopause Age on Gynecologic Cancer Risk: a Comprehensive Analysis Using NHANES Data

Overview

Journal Front Oncol

Specialty Oncology

Date 2025 Feb 26

PMID 40007994

Authors

Yiliminuer Abulajiang

Tao Liu

Ming Wang

Abidan Abulai

Yumei Wu

Affiliations

Soon will be listed here.

Abstract

Background: Menopause, a natural transition, affects women's health risks, including gynecologic cancers. Early menopause, linked to lower estrogen, may increase cancer susceptibility. This study analyzed NHANES data from 1999 to 2020 for 8,219 postmenopausal women to explore the relationship between menopausal age and gynecologic cancers. We used regression models and RCS models to assess the risk.

Methods: This study utilized data from the NHANES spanning 1999 to 2020, focusing on 8,219 postmenopausal women selected through stratified sampling. Variables including socioeconomic factors, health behaviors, nutritional status, and medical history were assessed in relation to participants' menopausal age and gynecologic cancer prevalence. We analyzed the relationship between menopausal age and gynecologic cancers (cervical, ovarian, and uterine) using multiple regression models. Additionally, we employed RCS models to evaluate nonlinear relationships between menopausal age and gynecologic cancer risk.

Results: Our findings indicate a significant inverse association between menopausal age and the risk of gynecologic cancers. After controlling for confounding factors such as age, race, BMI, and lifestyle variables, a later age at menopause was associated with a reduced risk of cervical, ovarian, and uterine cancers. The RCS model revealed a non-linear, low-L-shaped relationship, particularly highlighting increased cancer risks at younger menopausal ages. Subgroup analyses demonstrated consistent results across demographic and lifestyle factors, confirming the robustness of the observed associations.

Conclusion: This study reveals the link between menopausal age and gynecologic cancer prevalence. Early menopause is a significant risk factor for cervical, ovarian, and uterine cancers. Our findings support tailored cancer screening based on menopausal age, potentially improving preventive care for postmenopausal women.

References

Jimenez-Salazar J, Damian-Ferrara R, Arteaga M, Batina N, Damian-Matsumura P . Non-Genomic Actions of Estrogens on the DNA Repair Pathways Are Associated With Chemotherapy Resistance in Breast Cancer. Front Oncol. 2021; 11:631007. PMC: 8044931. DOI: 10.3389/fonc.2021.631007. View

Xing Z, Alman A, Kirby R . Premature Menopause and All-Cause Mortality and Life Span Among Women Older Than 40 Years in the NHANES I Epidemiologic Follow-Up Study: Propensity Score Matching Analysis. J Womens Health (Larchmt). 2023; 32(9):950-959. DOI: 10.1089/jwh.2023.0189. View

Louwers Y, Visser J . Shared Genetics Between Age at Menopause, Early Menopause, POI and Other Traits. Front Genet. 2021; 12:676546. PMC: 8529948. DOI: 10.3389/fgene.2021.676546. View

Dekker J, Karchoud J, Braamse A, Buiting H, Konings I, van Linde M . Clinical management of emotions in patients with cancer: introducing the approach "emotional support and case finding". Transl Behav Med. 2020; 10(6):1399-1405. PMC: 7796719. DOI: 10.1093/tbm/ibaa115. View

Lyu Y, Geng L, Wang F, Yang C, Rong S, Zhou H . Comparative analysis of pre- and postmenopausal endometrial cancer in 216 patients. Transl Cancer Res. 2023; 12(3):595-604. PMC: 10080312. DOI: 10.21037/tcr-22-1616. View

Karst A, Drapkin R . Ovarian cancer pathogenesis: a model in evolution. J Oncol. 2009; 2010:932371. PMC: 2739011. DOI: 10.1155/2010/932371. View

Jung S, Papp J, Sobel E, Pellegrini M, Yu H, Zhang Z . Pro-inflammatory cytokine polymorphisms and interactions with dietary alcohol and estrogen, risk factors for invasive breast cancer using a post genome-wide analysis for gene-gene and gene-lifestyle interaction. Sci Rep. 2021; 11(1):1058. PMC: 7807068. DOI: 10.1038/s41598-020-80197-1. View

Grady D, Gebretsadik T, Kerlikowske K, Ernster V, Petitti D . Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol. 1995; 85(2):304-13. DOI: 10.1016/0029-7844(94)00383-O. View

Al-Shami K, Awadi S, Khamees A, Alsheikh A, Al-Sharif S, Ala Bereshy R . Estrogens and the risk of breast cancer: A narrative review of literature. Heliyon. 2023; 9(9):e20224. PMC: 10559995. DOI: 10.1016/j.heliyon.2023.e20224. View

10.

Agnew H, Kitson S, Crosbie E . Gynecological malignancies and obesity. Best Pract Res Clin Obstet Gynaecol. 2023; 88:102337. DOI: 10.1016/j.bpobgyn.2023.102337. View

11.

Pan K, Chlebowski R, Mortimer J, Gunter M, Rohan T, Vitolins M . Insulin resistance and breast cancer incidence and mortality in postmenopausal women in the Women's Health Initiative. Cancer. 2020; 126(16):3638-3647. DOI: 10.1002/cncr.33002. View

12.

Crudele L, Piccinin E, Moschetta A . Visceral Adiposity and Cancer: Role in Pathogenesis and Prognosis. Nutrients. 2021; 13(6). PMC: 8234141. DOI: 10.3390/nu13062101. View

13.

Yang X, Wang J . The Role of Metabolic Syndrome in Endometrial Cancer: A Review. Front Oncol. 2019; 9:744. PMC: 6694738. DOI: 10.3389/fonc.2019.00744. View

14.

Wu Y, Sun W, Liu H, Zhang D . Age at Menopause and Risk of Developing Endometrial Cancer: A Meta-Analysis. Biomed Res Int. 2019; 2019:8584130. PMC: 6560333. DOI: 10.1155/2019/8584130. View

15.

Kroeger Jr P, Drapkin R . Pathogenesis and heterogeneity of ovarian cancer. Curr Opin Obstet Gynecol. 2016; 29(1):26-34. PMC: 5201412. DOI: 10.1097/GCO.0000000000000340. View

16.

Sapre S, Thakur R . Lifestyle and dietary factors determine age at natural menopause. J Midlife Health. 2014; 5(1):3-5. PMC: 3955043. DOI: 10.4103/0976-7800.127779. View

17.

Agnoli C, Grioni S, Pala V, Allione A, Matullo G, Di Gaetano C . Biomarkers of inflammation and breast cancer risk: a case-control study nested in the EPIC-Varese cohort. Sci Rep. 2017; 7(1):12708. PMC: 5629213. DOI: 10.1038/s41598-017-12703-x. View

18.

Hyvarinen M, Juppi H, Taskinen S, Karppinen J, Karvinen S, Tammelin T . Metabolic health, menopause, and physical activity-a 4-year follow-up study. Int J Obes (Lond). 2021; 46(3):544-554. PMC: 8605777. DOI: 10.1038/s41366-021-01022-x. View

19.

Shen X, Cheng Y, Ren F, Shi Z . The burden of cervical cancer in China. Front Oncol. 2022; 12:979809. PMC: 9530827. DOI: 10.3389/fonc.2022.979809. View

20.

Hernandez A, Pasupuleti V, Benites-Zapata V, Thota P, Deshpande A, Perez-Lopez F . Insulin resistance and endometrial cancer risk: A systematic review and meta-analysis. Eur J Cancer. 2015; 51(18):2747-58. DOI: 10.1016/j.ejca.2015.08.031. View